Prostate Cancer News

A new urine-based test for men with prostate cancer can distinguish the slow-growing form of the disease from the more aggressive type that would require immediate treatment, according to study data published in JAMA Oncology.

The American Urological Association released a clinical practice guideline pertaining to salvage therapy for men with prostate cancer.

A 10-minute video designed to educate Black men on prostate cancer risks prompted 93% of viewers to report they intend to be screened in the future, according to study results presented at American Association for Cancer Research Annual Meeting.

Individuals with cancer reported significantly reduced pain immediately following a 10-minute virtual reality (VR) session, study results published in Cancer showed.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive solid tumors who received previous systemic therapy and lack additional treatment options.

Fewer than one-third of recently approved molecular-targeted cancer therapies demonstrated “substantial patient benefits,” according to data published in JAMA Oncology.

Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.

Arya Amini, MD, still remembers sitting on the steps outside of his dean’s office at University of California, Irvine, more than a decade ago, prepared to race inside in case he did not get matched with a radiation oncology residency.

The FDA approved the first two denosumab biosimilars.

Adverse events experienced by men with prostate cancer varied considerably based on the treatment they received, results of a 10-year follow-up study showed.